Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001

Published:2015-06-04 Issue:25 Volume:6 Page:21547-21556
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ning Shoucheng¹,Sekar Thillai Veerapazham²,Scicinski Jan³,Oronsky Bryan³,Peehl Donna M.⁴,Knox Susan J.¹,Paulmurugan Ramasamy²

Affiliation:

1. Department of Radiation Oncology Stanford University Medical Center Stanford, CA 94305, USA

2. Department of Radiology Stanford University Medical Center Stanford, CA 94304, USA

3. EpicentRx, Inc., Mountain View, CA 94041, USA

4. Department of Urology Stanford University Medical Center Stanford, CA 94305, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist;Frontiers in Oncology;2023-05-29

2. Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials;Expert Opinion on Investigational Drugs;2023-03-22

3. A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation;Drugs;2023-03-15

4. RRx-001 and the “Right stuff”: Protection and treatment in outer space;Life Sciences in Space Research;2022-11

5. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets;Biomedicine & Pharmacotherapy;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP